Harbour Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Harbour Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	11,573 -7,578	-40%	-$1.02M	0.02%	576
2026 Q1	$2.45M	Buy	19,151 +18,134	+1,783%	+$2.26M	0.04%	434
2025 Q4	$124K	Buy	1,017 +262	+35%	+$30K	﹤0.01%	1524
2025 Q3	$75.7K	Buy	755 +111	+17%	+$10K	﹤0.01%	1695
2025 Q2	$53.4K	Sell	644 -6	-0.9%	-$479	﹤0.01%	1790
2025 Q1	$52.7K	Sell	650 -34	-5%	-$3.04K	﹤0.01%	1731
2024 Q4	$61.6K	Hold	684	–	–	﹤0.01%	1606
2024 Q3	$67.6K	Sell	684 -3,794	-85%	-$373K	﹤0.01%	1514
2024 Q2	$415K	Sell	4,478 -291	-6%	-$26.1K	0.01%	668
2024 Q1	$453K	Sell	4,769 -28	-0.6%	-$2.6K	0.02%	630
2023 Q4	$428K	Hold	4,797	–	–	0.02%	583
2023 Q3	$350K	Sell	4,797 -30	-0.6%	-$2.4K	0.02%	599
2023 Q2	$402K	Buy	4,827 +3,402	+239%	+$285K	0.02%	556
2023 Q1	$109K	Sell	1,425 -20	-1%	-$1.66K	0.01%	1004
2022 Q4	$120K	Sell	1,445 -320	-18%	-$25.9K	0.01%	937
2022 Q3	$131K	Hold	1,765	–	–	0.01%	861
2022 Q2	$131K	Buy	+1,765	New	+$132K	0.01%	861
2021 Q4	$229K	Sell	2,044 -7,645	-79%	-$922K	0.01%	666
2021 Q3	$1.22M	Buy	9,689 +2,009	+26%	+$259K	0.04%	397
2021 Q2	$1.04M	Buy	7,680 +445	+6%	+$58.5K	0.03%	451
2021 Q1	$981K	Buy	+7,235	New	+$1.08M	0.04%	420

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Harbour Investments's XBI Position: Q2 2026 in Review

Harbour Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 40% in Q2 2026, selling an estimated $1.02M and leaving 11,573 shares worth $1.83M. The position accounts for 0.02% of the portfolio, ranked #576.

Harbour Investments first reported a position in XBI in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.45M in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Harbour Investments held 11,573 shares of State Street SPDR S&P Biotech ETF worth $1.83M as of Q2 2026.
Harbour Investments sold 7,578 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.02M.
State Street SPDR S&P Biotech ETF made up 0.02% of Harbour Investments's portfolio in Q2 2026, its #576 holding.
Harbour Investments first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 21 quarters since.
Harbour Investments's State Street SPDR S&P Biotech ETF position peaked at $2.45M in Q1 2026.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.